# A Study for Patients With Multiple Sclerosis

> **NCT00870155** · PHASE2,PHASE3 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 546 (estimated)

## Conditions studied

- Secondary Progressive Multiple Sclerosis

## Interventions

- **DRUG:** dirucotide

## Key facts

- **NCT ID:** NCT00870155
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 546 (ESTIMATED)
- **Why stopped:** Negative efficacy results of the MAESTRO-01 trial
- **Last updated:** 2010-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870155, "A Study for Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00870155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*